日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A sustainable ROS cycle generator (SRCG) for tumor chemodynamic therapy

用于肿瘤化学动力疗法的可持续ROS循环发生器(SRCG)

Zhang, Yuling; Zeng, Silue; Tang, Chuanyu; He, Shuangqin; Pan, Yingying; Li, Shuchang; Ren, Yaguang; Li, Mifang; Tan, Jianwei; Zhang, Min; Chen, Jingqin; Liu, Chengbo; Zhang, Lingyan

Immune Imprinting Identified in Phage-Display Antibody Libraries Derived from Early Wild-Type and Late Omicron COVID-19 Convalescents

在源自早期野生型和晚期 Omicron COVID-19 康复者的噬菌体展示抗体库中发现了免疫印迹

Li, Boyang; Wang, Mengxuan; Huang, Fang; Wu, Wei; Fan, Jiaxin; Yang, Lu; Pan, Yongbing; Liang, Mifang; Duan, Kai

Multiparametric MRI-based habitat analysis integrating deep learning and radiomics for predicting preoperative Ki-67 expression level in breast cancer

基于多参数磁共振成像的生境分析,结合深度学习和放射组学,用于预测乳腺癌术前Ki-67表达水平

Wang, Yuqian; Zhang, Yue; Liu, Zaiyi; Xiong, Yiming; Li, Mifang; Zhang, Lingyan; Shi, Zhenwei

Photothermal and Combinatory Therapy as an Emerging Therapeutic Paradigm of Breast Cancer Treatment

光热疗法和联合疗法作为乳腺癌治疗的新兴治疗模式

Li, Mifang; Hasan, Ikram; Zhang, Lingyan; Peng, Tingting; Guo, Bing; Wang, Zun

Chloroquine Enhances Chemosensitivity of Breast Cancer via mTOR Inhibition

氯喹通过抑制mTOR增强乳腺癌的化疗敏感性

Lin, Zhihao; Xu, Yuting; Li, Mifang; Liu, Yibiao; Yu, Jianbo; Zhang, Lingyan

Longitudinal analysis of cytokine dynamics in severe fever with thrombocytopenia syndrome patients - High-incidence regions of China (2010-2023)

中国高发地区发热伴血小板减少综合征患者细胞因子动态的纵向分析(2010-2023)

Wen, Yanhan; Tong, Yeqing; Gong, Lei; Li, Aqian; Huang, Xiaoxia; Tian, Tingting; Liu, Tiezhu; Sun, Lina; Li, Jiandong; Li, Dexin; Liang, Mifang; Wu, Wei; Wu, Jiabing; Wang, Shiwen

Rapidly obtaining genome sequence of Severe Fever with Thrombocytopenia Syndrome virus directly from clinical serum specimen using long amplicon based nanopore sequencing workflow

利用基于长扩增子的纳米孔测序工作流程,直接从临床血清样本中快速获取发热伴血小板减少综合征病毒的基因组序列。

Tian, Tingting; Wen, Yanhan; Gao, Liping; Liu, Tiezhu; Huang, Xiaoxia; Li, Chuan; Du, Shanshan; Li, Hao; Guo, Meijun; Li, Jiandong; Wang, Shiwen; Li, Dexin; Li, Aqian; Liang, Mifang

Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China

在中国,2022年末至2023年初的COVID-19疫情期间,人源单克隆抗体F61鼻喷雾剂有效保护了高危人群免受SARS-CoV-2变异株的感染。

Liu, Ying; Zhang, Jiayou; Liu, Wen; Pan, Yongbing; Ruan, Shunan; Nian, Xuanxuan; Chen, Wei; Sun, Lina; Yin, Qiangling; Yue, Xin; Li, Qingliang; Gui, Fang; Wu, Cong; Wang, Shuzhen; Yang, Yunkai; Jing, Zhaofei; Long, Feiguang; Wang, Zejun; Zhang, Zeyu; Huang, Chaolin; Duan, Kai; Liang, Mifang; Yang, Xiaoming

Molecular insight into the neutralization mechanism of human-origin monoclonal antibody AH100 against Hantaan virus

从分子层面揭示人源单克隆抗体AH100对抗汉坦病毒的中和机制

Wang, Feiran; Liu, Tiezhu; Liao, Liying; Chai, Yan; Qi, Jianxun; Gao, Feng; Liang, Mifang; Gao, George Fu; Wu, Yan

Investigation of Nasal Mucosal IgA Responses in the Population Following COVID-19 Pandemic - China, September 2022-August 2023

新冠肺炎疫情后人群鼻黏膜IgA反应调查——中国,2022年9月至2023年8月

Li, Boyang; Zhou, Lei; Chen, Zhilong; Wen, Yanhan; Wang, Qian; Huang, Tao; Chen, Si; Wu, Wei; Wang, Mengxuan; Sun, Lina; Liang, Mifang; Wang, Shiwen; Chen, Ling; Li, Qun